✦ LIBER ✦

Analgesic tolerance without demonstrable opioid-induced hyperalgesia: A double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain

✍ Scribed by Larry F. Chu; Nicole D’Arcy; Caitlin Brady; Abigail Kathleen Zamora; Chelsea Anne Young; Julie Eunwoo Kim; Anna Marie Clemenson; Martin S. Angst; J. David Clark

Book ID: 116818951
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 220 KB
Volume: 153
Category: Article
ISSN: 0304-3959
DOI: 10.1016/j.pain.2012.02.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PR_183: Efficacy and Safety of Oxymorpho

PR_183: Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Low Back Pain: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

✍ Richard Rauck; Martin E. Hale; Tina Ma; Rosemary Kerwin; Harry Ahdieh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 55 KB

(248) Analgesic efficacy and safety of c

(248) Analgesic efficacy and safety of controlled-release hydrocodone and acetaminophen tablets, dosed twice daily, for moderate to severe mechanical chronic low-back pain: A randomized, double-blind, placebo-controlled withdrawal trial

✍ C. Codding; D. Levinsky; M. Hale; J. Thomas; E. Lockhart; R. Jain 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 40 KB

(259) Efficacy of oxymorphone extended r

(259) Efficacy of oxymorphone extended release in opioid-experienced patients with chronic low back pain due to a herniated disc: Subgroup analysis of a randomized, double-blind, placebo-controlled trial

✍ M. Hale; T. Ma; H. Ahdieh; R. Kerwin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Efficacy and Safety of OPANA ER (Oxymorp

Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study

✍ Martin E. Hale; Harry Ahdieh; Tina Ma; Richard Rauck 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 317 KB

(256) Subject’s and physician’s global a

(256) Subject’s and physician’s global assessment of chronic low-back pain status after treatment with 12-hour extended-release hydrocodone/acetaminophen tablets: A 3-week open-label, 12-week randomized double-blinded placebo-controlled withdrawal trial

✍ C. Codding; D. Levinsky; M. Hale; J. Thomas; P. Vo; S. Marx; E. Lockhart; R. Jai 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 40 KB